Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease

Abstract

Exercise rehabilitation is a proven, yet poorly available, treatment for intermittent claudication, the primary symptom of peripheral arterial disease (PAD). Exercise rehabilitation is effective, non-invasive, and associated with minimal cardiovascular risk in appropriate patients. Percutaneous transluminal angioplasty (PTA), especially of the iliac segment, is an alternative effective treatment for claudication. There are, however, minimal data currently available to compare the cost-effectiveness of these two interventions. We compared the cost-effectiveness of 3- and 6-month exercise programs with that of iliac PTA without stenting, using the incremental cost-effectiveness ratio [ICER ¹/4 (Cost2 Cost1)=(Effectiveness2 Effectiveness1)]. The ICER represented the price of an additional meter walked derived from each treatment based on conservative models of success of each procedure and specific care assumptions. PTA and exercise efficacy data were derived from a literature review and exercise costs were modeled per the current CPT code 93668. Effectiveness was defined as absolute claudication distance (ACD) at 3 and 6 months. Three treatment alternatives were assessed: (1) no treatment, (2) PTA, and (3) exercise rehabilitation. At 3 months, PTA was more effective than exercise therapy and resulted in an additional 38 meters at an additional cost of $6719, for an ICER of $177=meter. At 6 months, however, exercise was more effective than PTA, resulting in an additional 137 meters walked, and costs less ($61 less per meter gained). In conclusion, exercise rehabilitation at 6 months is more effective and costs less than PTA, and is therefore cost-saving. The cost-effectiveness and availability of claudication treatments has national implications for future PAD care; however, data to inform these care choices can best be obtained in prospective clinical trials.

Keywords

claudication cost-effectiveness exercise outcomes assessment percutaneous transluminal angioplasty peripheral arterial disease

References

Treat-Jacobson DT , Halverson SL , Ratchford A , Regensteiner JG , Lindquist R , Hirsch AT. A patient-derived perspective of health-related quality-of-life in peripheral arterial disease. J Nurs Scholarsh 2002; 34: 55-60.

McDermott MM , Greenland P , Liu K et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 2001; 286: 1599-1606.

Breek JC , Hamming JF , De Vries J , van Berge Henegouwen DP , van Heck GL. The impact of walking impairment, cardiovascular risk factors, and comorbidity on quality of life in patients with intermittent claudication. J Vasc Surg 2002; 36:94-99.

Barletta G , Perna S , Sabba C , Catalano A , O’Boyle C , Brevetti G. Quality of life in patients with intermittent claudication: relationship with laboratory exercise performance. Vasc Med 1996; 1:3-7.

Khaira HS , Hanger R , Shearman CP. Quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg 1996; 11:65-69.

Vogt MT , Cauley JA , Kuller LH , Nevitt MC. Functional status and mobility among elderly women with lower extremity arterial disease: the Study of Osteoporotic Fractures. J Am Geriatr Soc 1994; 42: 923-929.

Pell JP for the Scottish Vascular Audit Group .Impactofintermittent claudication on quality of life. Eur J Vasc Endovasc Surg 1995; 9:469-472.

Ponte E , Cattinelli S. Quality of life in a group of patients with intermittent claudication. Angiology 1996; 47: 247-251.

Regensteiner JG , Treat-Jacobson D , Walsh ME et al. PARTNERS: The Impact of Peripheral Arterial Disease (PAD) on Health-Related Quality of Life (HQL). Circulation 2000; 102(18) (suppl II): II 400-II 400.

10.

Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001; 344: 1608-1621.

11.

Hirsch AT , Criqui MH , Treat-Jacobson D et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-1324.

12.

Stewart KJ , Hiatt WR , Regensteiner JG , Hirsch AT. Medical progress: exercise training for claudication. N Engl J Med 2002; 347:1941-1951.

13.

Currie IC , Wilson YG , Baird RN , Lamont PM. Treatment of intermittent claudication: the impact on quality of life. Eur J Vasc Endovasc Surg 1995; 10: 356-361.

14.

Hiatt WR , Regensteiner JG , Hargarten ME , Wolfel EE , Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation 1990; 81: 602-609.

15.

Hiatt WR , Hirsch AT , Regensteiner JG , Brass EP and the Vascular Clinical Trialists . Clinical trials for claudication: assessment of exercise performance, functional status, and clinical end points. Circulation 1995; 92: 614-621.

16.

Hirsch AT , Reich L. Intermittent claudication. Curr Treat Options Cardiovasc Med 2001; 3: 167-180.

17.

Gardner AW , Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 1995; 274:975-980.

18.

Leng GC , Fowler B , Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev 2000(2); CD000990.

19.

Patterson RB , Pinto B , Marcus B , Colucci A , Braun T , Roberts M. Value of a supervised exercise program for the therapy of arterial claudication. J Vasc Surg 1997; 25:312-319.

20.

Regensteiner JG , Steiner JF , Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg 1996; 23:104-115.

21.

Hiatt WR , Wolfel EE , Meier RH , Regensteiner JG. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Circulation 1994; 90: 1866-1874.

22.

Regensteiner JG , Meyer TJ , Krupski WC , Cranford LS , Hiatt WR. Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology 1997; 48:291-299.

23.

Degischer S , Labs KH , Hochstrasser J , Aschwanden M , Tschoepl M , Jaeger KA. Physical training for intermittent claudication: a comparison of structured rehabilitation versus home-based training. Vasc Med 2002; 7:109-115.

24.

TASC Working Group . Management of peripheral arterial disease (PAD). J Vasc Surg 2000; 31 (suppl pt 2): S54-S134.

25.

American Medical Association . Current procedural terminology (CPT). Chicago, IL: AMA, 2001.

26.

Bosch JL , Hunink MGM. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997; 204:87-96.

27.

Creasy TS , McMillan PJ , Fletcher EWL , Collin J , Morris PJ. Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. Eur J Vasc Surg 1990; 4: 135-140.

28.

Laborde JC , Palmaz JC , Rivera FJ , Encarnacion CE , Picot MC , Dougherty SP. Influence of anatomic distribution of atherosclerosis on the outcome of revascularization with iliac stent placement. JVasc Interv Radiol 1995; 6: 513-521.

29.

Stokes KR , Strunk HM , Campbell DR , Gibbons GW , Wheeler HG , Clouse ME. Five-year results of iliac and femoropopliteal angioplasty in diabetic patients. Radiology 1990; 174:977-982.

30.

Palmaz JC , Laborde JC , Rivera FJ , Encarnacion CE , Lutz JD , Moss JG. Stenting of the iliac arteries with the Palmaz stent: experience from a multicenter trial. Cardiovasc Interv Radiol 1992; 15:291-297.

31.

Sapoval MR , Chatellier G , Long AL et al. Self-expandable stents for the treatment of iliac artery obstructive lesions: long-term success and prognostic factors. Am J Roentgenol 1996; 166: 1173-1179.

32.

Timaran CH , Stevens SL , Freeman MB , Goldman MH. External iliac and commonilia cartery angioplasty and stenting in men and women. J Vasc Surg 2001; 34: 440-446.

33.

Gold MR , Siegel JE , Russell LB , Weinstein MC (eds). Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.

34.

Perkins JM , Collin J , Creasy TS , Fletcher EW , Morris PJ. Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. Eur J Vasc Endovasc Surg 1996; 11:409-413.

35.

Bureau of Labor Statistics. The US Department of Labor.[Accessed 7/25/2001.] Available at: http://www.bls.gov/blshome.htm

36.

HealthCare Consultants . 2001 Physicians fee guide. Augusta, GA: HealthCare Consultants of America, Inc., 2000: 65-65.

37.

Bosch JL , Haaring C , Meyerovitz MF , Cullen KA , Hunnink MGM. Cost-effectiveness of percutaneous treatment of iliac artery occlusive disease in the United States. Am J Radiol 2000; 175: 517-521.